Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

miniGITA Dual · Radio-TLC + Gamma Spectrometry — what the literature says.

Five real anchor citations across the workflows the miniGITA Dual is bought for — high-volume Tc-99m radiopharmaceutical release, modern two-strip TLC method development, Ga-68 DOTATATE HPLC-validated release, Lu-177 PSMA I&T theranostic release, and the honest limits of TLC-only QC that make the Dual's combined radio-TLC + gamma-spec architecture valuable. Every DOI and journal reference verified.

99.74 %2 280-procedure Tc-99m release pass rate (Maioli 2017)
≥ 94 %Eur.Ph. %RCP release threshold — Tc-99m MAG3 (Straub 2018)
TLC + γcombined release path — radiochemical + radionuclidic on one instrument
Filter
Three-year QC cohort — Maioli 2017
2 280
QC procedures performed
99.74 %
Eur.Ph. pass rate
≥ 80 – 95 %
Eur.Ph. %RCP thresholds
Six of 2 280 preparations (0.26 %) failed release and were repeated / investigated. Eur.Ph. %RCP thresholds vary per radiopharmaceutical from ≥ 80 % (looser kits) to ≥ 95 % (stringent Tc-99m MDP / MIBI / MAG3). Radio-TLC as the release-gate modality is quantified in this cohort.
Volume · daily release2017
99.74 %2 274 of 2 280 Tc-99m preparations passed Eur.Ph. radiochemical-purity release across three years — the volume study that anchors radio-TLC as the SPECT-radiopharmacy workhorse QC modality

Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling — three years of experience on 2 280 procedures

Acta Biomedica 88(1) — Maioli, Lucignani, Strinchini, Tagliabue, Del Sole (Milan)

Two-strip TLC scope — Straub 2018
~ 20 min
Total analysis time
≥ 94 %
Eur.Ph. %RCP threshold (MAG3)
2 strips
lipophilic + hydrophilic
Strip 1 separates ⁹⁹ᵐTcO₄⁻ and Tc-MAG2; strip 2 identifies colloidal ⁹⁹ᵐTc and tartrate complexes. Modern reference method for MAG3 renal-scan release — the model for radio-TLC method development at the daily-dispensing bench.
Method — Tc-99m MAG32018
~ 20 minTwo parallel strips — 60:40 ethyl acetate / MEK for lipophilic impurities + 90:10 ethanol / water for hydrophilic ones — deliver the full Eur.Ph. ≥ 94 % release decision for Tc-99m MAG3 within one dispensing window

A new two-strip TLC method for the quality control of technetium-99m mercaptoacetyl-triglycine (⁹⁹ᵐTc-MAG3)

EJNMMI Radiopharmacy and Chemistry 3:5 — Straub, Leresche, Pilloud, Devynck, Stritt, Hesselmann

Ga-68 DOTATATE HPLC validation — Sammartano 2023
r² 0.9998
linearity (0.5 – 3 μg/mL)
± 5 %
accuracy bias
0.1 μg/mL
LOD
ICH Q2 (R1) + EDQM-guided HPLC validation. Anchors the Dual's radio-TLC + gamma-spec approach as a cost-effective Ga-68 DOTATATE release path meeting the same %RCP + radionuclidic-identity requirements as a full HPLC workflow.
Ga-68 DOTATATE2023
r² 0.9998Ga-68 DOTATATE HPLC linearity 0.5 – 3 μg/mL with r² 0.9998, precision CV 0.20 – 0.61 %, accuracy bias within ±5 %. Anchors the Dual's combined radio-TLC + gamma-spec release path against the same Ph.Eur.-compliant standard

Validation of the HPLC analytical method for the determination of chemical and radiochemical purity of Ga-68-DOTATATE

Indian Journal of Nuclear Medicine 38(1) — Sammartano, Migliari, Serreli, Scarlattei, Baldari, Ruffini

[¹⁷⁷Lu]Lu-PSMA I&T release — TLC + HPLC — Kraihammer 2023
Release gate
Radio-TLC (citrate buffer)
separates free Lu-177 vs colloid vs product; quantifies free Lu-177 even in DTPA formulations
vs
Confirmation
Radio-HPLC (C-12 gradient)
99.0 ± 0.04 % recovery; resolves the deiodinated natLu-PSMA I&T impurity from radiolysis
Lu-177 theranostic2023
96.9 % RCPValidated HPLC + TLC combination for [¹⁷⁷Lu]Lu-PSMA I&T release — mean radiochemical purity 96.9 ± 0.5 % across the batch cohort against a ≥ 95 % Ph.Eur. threshold. TLC separates free Lu-177 + colloid impurities even in the presence of DTPA; HPLC resolves the natLu-PSMA I&T deiodination product

Improved quality control of [¹⁷⁷Lu]Lu-PSMA I&T

EJNMMI Radiopharmacy and Chemistry 8:7 (open access) — Kraihammer, Garnuszek, Bauman, Maurin, Alejandre Lafont, Haubner, von Guggenberg, Gabriel, Decristoforo

TLC limits vs multi-method — Migliari 2024
TLC
quantifies free vs bound
HPLC
distinguishes bound species
γ-spec
radionuclidic identity + purity
Radio-TLC is the release gate; radio-HPLC or gamma-spec is the identity + integrity check. The Dual's two-position architecture (TLC scanner + gamma-spec probe) delivers both release paths from one instrument, one QC session and one batch record.
Method limits · TLC vs HPLC2024
TLC alone: noHonest-limits paper — TLC alone cannot distinguish [⁶⁸Ga]Ga-HSA from the target [⁶⁸Ga]Ga-MAA aggregate. The Dual answers this by pairing radio-TLC with a fixed gamma-spec probe on the same instrument for combined radiochemical + radionuclidic release

Validation of a radiosynthesis method and a novel QC system for [⁶⁸Ga]Ga-MAA — is TLC enough to assess radiopharmaceutical quality?

EJNMMI Radiopharmacy and Chemistry 9:70 — Migliari, Bruno, Bianchera, De Nardis, Scarano, Lusardi, Gaiani, Guercio, Scarlattei, Baldari, Bettini, Ruffini

miniGITA Dual

More for this product

Each card opens a focused post for a specific specialty — clinical workflow and evidence, written for the persona you select.

Literature Radar · auto-updated daily

Latest radiopharmacy QC research

Fresh peer-reviewed papers on radiopharmaceutical release testing — Tc-99m / F-18 / Ga-68 / Lu-177 %RCP by radio-TLC and radio-HPLC, radionuclidic identity, Mo-99 / Ge-68 / Lu-177m breakthrough. Auto-updated from Europe PMC.

See all in radar →
Loading recent papers…